Skip to main content

View full-text article in PMC

. 2020 Mar 20;22(3):e16810. doi: 10.2196/16810

Table 3.

Breakdown of Cancer Gene Trust data by patient and modality.

CGT^a	Clinical		Genomics		Imaging		OMOP^b data breakdown
CGT Public UUID^c	Registry	OMOP	FMI^d	UCSF^e 500	CT^f	Pathology	Conditions	Procedures	Drugs
f9b6a782-bbf5-4be8-bf7e-d1a9586d9552	✓	✓	✓	N/A^g	N/A	N/A	1597	1190	3661
c2e2e081-4c39-4201-8a27-7b469ed39490	✓	✓	✓	N/A	✓	✓	1350	969	2088
db2d85aa-4f94-4e77-8755-6b94a710c1aa	✓	✓	✓	N/A	✓	✓	2389	1394	3086
2fbc25da-3965-49c4-866f-72cf0abc2417	✓	✓	✓	N/A	N/A	N/A	930	654	1174
940171e7-d358-463a-8d9a-2b2fa90c2a84	✓	✓	✓	N/A	N/A	N/A	1179	624	1388
f0314175-2d19-4146-8754-fc5aed3ab420	✓	✓	✓	N/A	N/A	N/A	511	405	549
c7dbcfac-37ea-43f8-8899-1a9f2fb56341	✓	✓	✓	N/A	N/A	N/A	216	114	184
ef5c3164-6f45-4d3a-88f0-4509226c5571	✓	✓	N/A	✓	N/A	N/A	51	14	57
ec3d977b-c310-4df3-a444-f79bc3dd8b58	✓	✓	N/A	✓	N/A	N/A	811	505	776
131cf62d-ad78-49c1-a699-5bcc1004cd12	✓	✓	✓	N/A	N/A	N/A	155	42	110
cf11c31c-f4c3-48ba-9c46-66f406d0b7a1	✓	✓	✓	N/A	N/A	N/A	311	162	131
ccc2ba97-912f-4b62-b767-cca129ee6a56	✓	✓	N/A	✓	N/A	N/A	51	10	60
104ec531-5d95-41e2-ac72-f6cff2006b8e	✓	✓	✓	N/A	N/A	N/A	36	10	17
a5627ac3-450d-4036-ade8-99ae62a5c232	✓	✓	N/A	✓	N/A	N/A	857	439	805
5189efbe-3382-4353-ad2f-9afd0255c2c8	✓	✓	✓	N/A	N/A	N/A	875	276	674
253f0e2d-bebd-464b-81c5-8dd8385192b3	✓	✓	N/A	N/A	N/A	N/A	117	116	217
d199cfb0-91e8-471d-b1b3-53189cd64ee0	✓	✓	✓	N/A	✓	N/A	21	11	81
5d3205a3-28c4-45eb-bfd8-b32d67c3be0f	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

^aCGT: Cancer Gene Trust.

^bOMOP: Observational Medical Outcomes Partnership.

^cUUID: universally unique identifier.

^dFMI: Foundation Medicine.

^eUCSF: University of California, San Francisco

^fCT: computed tomography.

^gN/A: not applicable.